Ubicom Holdings. Inc. · TSE:3937
Ubicom — Q2 FY2024 Earnings Presentation
34 slides from Ubicom's earnings presentation, Nov 7, 2024
Slide 1: FY2024 Q2 Financial Results Materials
Ubicom Holdings, Inc. (Prime Market of TSE: 3937) FY2024 Q2 Financial Results Materials November 7, 2024
Slide 2: Table of Contents
Table of Contents 01 Overview of consolidated financial results (P/L) for FY2024 Q2 P3 02 Medical Business P6 03 Technology Consulting Business P19 04 Dividend Policy P27 05 Appendix P29 © Ubicom Holdings, Inc. 2
Slide 3: Overview of Consolidated Financial Results (P/L) for 2Q of FY2024
Overview of Consolidated Financial Results (P/L) for 2Q of FY2024 Sales・Operating income・Ordinary income・Net income All sections reached record highs in the second quarter. The improvement in net income resulted in an increase in ROE certainly, which is progressing as planned. Sales 2Q of FY2023 (Ac
Slide 4: Overview by segment for 2Q of FY2024
Overview by segment for 2Q of FY2024 (Business performance and ratios) ➀ Medical business ～Provision of management supporting solutions for medical institutions～ Business segments ② Technology consulting business ～Lab-based partnership and offshore transfer consulting～ Medical business Technology co
Slide 5: Our Business Model
Our Business Model: A model for issue resolutions in Japan, a developed country facing challenges 01 Medical Business 02 Technology Consulting Business Reforming the workstyle of Addressing the shortage medical professionals of 787,000* IT engineers Improving the profitability Mission by 2030 of med
Slide 6: Medical Business
Medical Business 6
Slide 7: Medical Business: Overview by segment for 2Q of FY2024
Medical Business： 2Overview by segment for 2Q of FY2024 (Business Performance) Both sales and operating income reached record highs due to the 1000 expansion of high profit base of AI × Subscription model. 950 900 850 Sales 2Q of FY2023 (Accumulated) 2Q of FY2024 (Accumulated) YoY 800 (Unit: million
Slide 8: Expansion of high profit base by AI×Subscription model
Expansion of High profit base by AI×Subscription model Medical Business Operating income ratio rose Performance Trends 4.6% in the first half of the prior year to a record high of 64.4 ％ Operating profit （unit : million yen） margin in the first 1,800 half of this year 65.0% 61.4% 1,600 64.4% 58.9% O
Slide 9: User's trend of the Core Solution Mighty series
AI×Subscription model User’s trend of the Core Solution「Mighty」series The application of workstyle reforms for medical doctors in April 2024 has led to an acceleration of digital transformation in the medical industry. The number of users is increasing steadily. （2Q accumulated+686） (+1,660) (+682)
Slide 10: Introduction of core products of the Mighty Series
AI×Subscription model Introduction of core products of the Mighty Series ※1 Electronic medical record (EMR) linked systemReturn on investment: 1,154% (e.g. Sales growth in a medium-sized hospital with 300 beds: 61,980,000 yen/year) System for supporting medical doctors in inputting disease names in
Slide 11: Measures to Expand Orders
「Mighty QUBE® Hybrid」 「MightyChecker® EX」 Measures to Expand Orders 11
Slide 12: Deploying cross-selling measures of Mighty QUBE Hybrid
Deploying cross-selling measures of「Mighty QUBE® Hybrid」 Small and medium-sized hospitals make up 91% of all hospitals and we will enhance marketing target at them. Through the alliances with electronic medical record manufacturers mainly for small and medium-sized hospitals, the sales of “Mighty QU
Slide 13: Deploying cross-selling measures of Mighty QUBE Hybrid
Deploying cross-selling measures of「Mighty QUBE® Hybrid」 Measure １ Installed to Small and Medium sized Hospitals with EMR(49%: 3,627 inst.) MightyChecker® We are launching cross-selling initiative for electric medical record manufacturers serving existing small and medium size hospitals. Started a n
Slide 14: Market trend and marketing strategy: Mighty QUBE Hybrid in clinics
Market trend and marketing strategy: Enhanced sale of Mighty QUBE® Hybrid in the field of clinics We start supplying products as an OEM for the cloud-type electronic medical record for home healthcare “homis” of MedicalInformatics Co., Ltd. Enhancement of sale of Mighty QUBE® Hybrid in a bundle to t
Slide 15: Expanded sales of MightyChecker EX in the clinic market
Market Trends & Marketing Strategy：Expanded sales of MightyChecker® EX in the clinic market Switching users of the old model (MightyChecker®for ORCA) to the new model (MightyChecker® EX) will increase the unit price by approx. 1.5 times. Contribute to increase in sales & profit. Replacement リプレイス状況
Slide 16: Promotion of the switch to MightyChecker EX
Marketing strategy: Promotion of the switch to MightyChecker® EX after the termination of support for the old product By switching existing users from the old product (Mighty Checker PRO) to the new product (MightyChecker® EX), the unit price has increased, which has contributed to sales profits. (*
Slide 17: Developing multiple new platforms for the Second Growth Phase
Developing multiple new platforms for the Second Growth Phase Expanding new platform business by utilizing Clients & Medical Data base and Intellectual properties. We aim to further develop a new recurring model to increase sales and profits. New target markets in Stable earnings the second growth p
Slide 18: Installation results and progress of Insurance Knowledge Platform
Installation results and progress of Insurance Knowledge Platform A solution for the insurance industry to assist in improving the efficiency of claims payment operations, utilizing a proprietary medical database backed by a track record of providing services to more than 20,000 medical institution
Slide 19: Technology Consulting Business
Technology Consulting Business 19
Slide 20: Technology Consulting Business: Overview by Segment for 2Q of FY2024
Technology Consulting Business： Overview by Segment for 2Q of FY2024 (Business Performance) 4,000 Sales reached a record high and Operating Income increased. 3,500 3,000 2,500 Sales 2Q of FY2023 (Accumulated) 2Q of FY2024 (Accumulated) YoY 2,000 (Unit: million yen) 2,131 2,297 comparison 1,500 Amoun
Slide 21: Strengthening the marketing for consulting services after organizational reform
Strengthening the marketing for consulting services after organizational reform and results Started consulting business for major domestic and overseas companies, utilizing 30 years of know-how in offshore development 【 Supporting customers with a “one-stop service” from upstream to downstream 】 Req
Slide 22: Technology Consulting Business Customer Trends
Technology Consulting Business Customer Trends By expanding existing customer transactions and acquiring new customer, the sales revenue is steadily increasing. ①SIer and large customers are rapidly reconsidering their supplies due to the impact of external environment. Our customers, SIer and large
Slide 23: Win-Win investment model: APAMAN Group strategic partnership
Win-Win investment model The agreement to establish a strategic partnership with APAMAN Group To build a strategic partnership with APAMAN Group, we are expanding labs at our Philippines offshore base and implementing organizational restructuring to create a team capable of handling large projects w
Slide 24: Implementing multiple measures to increase operating income
Implementing multiple measures to increase operating income （Technology consulting business） The 2nd growth phase（ medium/long-term vision ） 10000 New market and Measures to improve operating margin 9000 ➀ ② ③ Up utilization rate Launch Expansion business 8000 consulting business by highly skilled A
Slide 25: Business Forecast
Business Forecast 25
Slide 26: Business results and Promotion of measures in the second growth phase
Business results and Promotion of measures in the second growth phase ① Operation of multiple new platforms (medical business) ② Full-scale launch of Mighty QUBE® Hybrid and MightyChecker® EX’s cross-selling (medical business) ③ Enhancement of marketing for consulting in Japan through organizational
Slide 27: Dividend Policy
Dividend Policy 27
Slide 28: Dividend policies for sharing benefits from company growth
Dividend policies for enabling shareholders to share benefits from the growth of our company 【Dividend policies】 ➀ We aim to distribute profits to shareholders stably. ② To increase the dividend amount about three times from the previous fiscal year, while maintaining a good balance between the grow
Slide 29: Appendix
Appendix 29
Slide 30: Promotion of our group's business that is socially meaningful
Promotion of our group’s business that is socially meaningful Considering business and capital alliances with leading global companies for the second growth phase Provision of solutions that are beneficial to three things: workstyles reforms for medical Growing demand due to the doctors, which are b
Slide 31: ESG: For sustainable growth of business, society, and client companies
ESG：For sustainable growth of business, society, and client companies Goals Concrete activities Related SDGs ・To make the electric power consumed at ・To reduce CO2 emissions E the head office 100% derived from renewable energy ・Global partnership ・Investment in equipment of subsidiaries in the Phili
Slide 32: Corporate Profile
Corporate Profile ■Corporate name: Ubicom Holdings, Inc. (Prime Market of TSE: 3937) ■Strategic markets: healthcare, finance, public services, automobiles, manufacturing, robotics, etc. ■Business description: Technology Consulting Business In order to solve the problem of shortage of IT engineers an
Slide 33: Cautionary Note Regarding Forward-Looking Statements
Cautionary Note Regarding Forward-Looking Statements ▪ The materials and information provided in this announcement include forward-looking statements based on our current estimates and expectations at this point of time. ▪ Such forward-looking statements are subject to various risks and uncertaintie
Slide 34: © Ubicom Holdings, Inc.
Ubicom Holdings, Inc. y f was 34